Compare Pfizer Inc (PFE) vs Yum! Brands, Inc. (YUM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Pfizer Inc vs Yum! Brands, Inc. — how do they compare? Pfizer Inc trades at $28.13 (market cap $158.56B), while Yum! Brands, Inc. trades at $144.46 (market cap $39.02B). The key difference: Pfizer Inc is far larger — about 4.1× Yum! Brands, Inc.'s market cap, and Pfizer Inc pays the higher dividend (6.18%). Which is the better fit depends on your goals — on Pluang, investors hold Pfizer Inc for 158 Days and Yum! Brands, Inc. for 132 Days on average.
| PFE | YUM | |
|---|---|---|
Market Cap | $158.56B | $39.02B |
Volume | 44,138,282 | 2,597,636 |
Sector | Health | Consumer Cyclical |
52-Week High | $29.02 | $168.16 |
52-Week Low | $23.67 | $135.77 |
Typical Hold Time | 158 Days | 132 Days |
Enterprise Value | $210.06B | $50.63B |
Dividend Yield | 6.18% | 2.1% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Pfizer (PFE) trades at $28.00, up 1.87% on the day, with a bullish technical signal from moving averages. The company reported revenue of $62.58 billion in 2025 with a net income margin of 6.8%, and has beaten EPS estimates for the last three quarters. Recent news highlights Pfizer's focus on its obesity and oncology pipeline as key growth drivers in 2026.
The stock presents a value opportunity with a consensus price target of $29.17, but faces risks from patent expirations and projected earnings decline. Investor sentiment is mixed, with analysts largely neutral, emphasizing the stock's defensive cash flow and dividend yield amid ongoing business transformation.
YUM trades at $140.35, up 0.36% today, with a bullish technical signal despite mixed moving averages. Revenue grew to $8.21B in 2025, with net income of $1.56B and strong cash flow. Recent news highlights KFC's Open House launch and the completed Pizza Hut sale, streamlining the portfolio. Analysts maintain a consensus Buy rating with a $170.44 target, though some express caution amid sector pressures.
The outlook is positive with earnings beats and strategic refocusing, but risks include high debt levels and consumer spending sensitivity. Upside potential exists if growth initiatives succeed, yet investors should weigh competitive and macroeconomic headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Pfizer Inc
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →About Yum! Brands, Inc.
Yum Brands is a U.S.-based restaurant operator featuring a portfolio of four brands: KFC (26,930 global units), Pizza Hut (18,380 units), Taco Bell (7,790 units), and The Habit Burger (310 units) at year-end 2021. With $58 billion in 2021 systemwide sales, the firm is the second-largest restaurant company in the world, behind McDonald's ($112.5 billion) but ahead of Restaurant Brands International ($36 billion) and Starbucks ($25 billion). Yum is 98% franchised, with the largest franchisee, Yum China, created via a 2016 spinoff transaction (after which Yum China agreed to pay 3% royalties to Yum Brands in perpetuity). Yum is the newest evolution of Tricon Brands, formerly a division of PepsiCo, and generates the bulk of its revenue from franchise royalties and marketing contributions.
Read more on YUM →
